Revolutionize your gene therapy manufacturing with
Cellevat3d® nanofiber microcarriers
Exclusive global pre-launch at CPHI Milan,
October 8-10 2024.
Cellevat3d® nanofiber microcarriers
Designed for highest yield and productivity in upstream bioprocessing of gene therapy applications.
Commercial launch November 2024.
Cellevate – Advancing life-changing therapies for a healthier world
Cellevate AB is a biotech company offering next-generation microcarriers and macrocarriers for upstream bioprocessing, powered by our proprietary nanofiber technology, Cellevat3d®. This highly versatile and customizable technology provides an unparallelled surface area that faithfully replicates the human body’s extracellular environment. Cellevat3d® is scalable from R&D to commercial production, green and sustainable and enables the development of improved cell culture systems for cell and gene therapy as well as novel vaccines production.
Cellevat3d® is a game-changer in biopharmaceutical development and production, delivering significantly increased yield and reduced cost improving overall process productivity. Cellevate collaborates globally with numerous CDMOs and biopharmaceutical companies to drive innovation in bioproduction and advance life-changing therapies for a healthier world.
Pre-order
Contact us to book a meeting, enquire about collaboration or pre-order products.
Cellevat3d® product overview
Harness the power of nanofiber microcarriers and macrocarriers
Enhanced product titers in upstream bioprocessing
Nanofiber microcarriers provide up to 60x larger surface area-to-volume ratio than current microcarriers, supporting higher cell densities and enhancing viral vector production titers.
Optimal conditions for cell growth
Nanofiber microcarriers support the formation of spheroids, providing a true 3D (three-dimensional) cell culture environment, generating high viable cell densities (VCD) in stirred tank bioreactors.
Scalable from lab- to large-scale
Nanofiber cell culture systems are easily scaled-up from cell culture flasks to large stirred tank bioreactors.
Exceptional flexibility
Nanofiber material can be functionalized and easily molded into any shape or form, allowing for integration in various production platforms for gene therapy, cell therapy and novel vaccines.
Increased productivity and improved process economy
Improved cell culture product yield, faster processes, and scale-up result in an enhanced process economy.
The Cellevate journey
Take part of our story and see the highlights of Cellevates journey, from a spin-out of Lund University to a key industrial supplier for the biopharmaceutical industry.
About the company
Meet our experienced management team, the board of directors, and our investors who together drive the company forward, drawing on decades of proven expertise in building companies and scaling organizations through the successful development and commercialization of innovative products for the global biotech market.
News
Let’s talk
Contact us through the form below to pre-order Cellevat3d® nanofiber microcarriers starter pack, book a meeting, or ask us questions.
By clicking “Submit” I agree to the general terms and conditions of Cellevate’s privacy policy.
